THE IMPACT OF PURINE DERIVATIVES THERAPY FOR PATIENTS WITH MEDICATION-RELATED OSTEONECROSIS OF THE JAW: PRELIMINARY RESULTS FROM A PILOT STUDY

THE IMPACT OF PURINE DERIVATIVES THERAPY FOR PATIENTS WITH MEDICATION-RELATED OSTEONECROSIS OF THE JAW: PRELIMINARY RESULTS FROM A PILOT STUDY

Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive drugs – Bisphosphonates (BPs) and RANKL inhibitor (denosumab) – prescribed for treatment of bone malignancies and severe osteoporosis. Non-surgical treatment may be a valid option for MRONJ in patients inel...

Full description

Bibliographic Details
Main Authors: Nader Farajollah, Octavian Marius Dincă, George Cristian Vlădan, Tiberiu Niță, Lavinia Cristina Pădurariu, Alexandru Bucur
Format: Article
Language:English
Published: Romanian Society of Oral Rehabilitation 2024-09-01
Series:Romanian Journal of Oral Rehabilitation
Subjects:
mronj
purine derivatives
pentoxifylline
tocopherol
Online Access:https://rjor.ro/the-impact-of-purine-derivatives-therapy-for-patients-with-medication-related-osteonecrosis-of-the-jaw-preliminary-results-from-a-pilot-study/

Internet

https://rjor.ro/the-impact-of-purine-derivatives-therapy-for-patients-with-medication-related-osteonecrosis-of-the-jaw-preliminary-results-from-a-pilot-study/

Similar Items